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ABSTRACT Influenza virus hemagglutinin (HA)-mediated membrane fusion involves insertion into target membranes of a
stretch of amino acids located at the N-terminus of the HA2 subunit of HA at low pH. The pKa of the -amino group of
1Gly
of the fusion peptide was measured using 15N NMR. The pKa of this group was found to be 8.69 in the presence of DOPC
(1,2-dioleoyl-sn-glycero-3-phosphocholine). The high value of this pKa is indicative of stabilization of the protonated form of
the amine group through noncovalent interactions. The shift reagent Pr3 had large effects on the 15N resonance from the
-amino group of Gly1 of the fusion peptide in DOPC vesicles, indicating that the terminal amino group was exposed to the
bulk solvent, even at low pH. Furthermore, electron paramagnetic resonance studies on the fusion peptide region of
spin-labeled derivatives of a larger HA construct are consistent with the N-terminus of this peptide being at the depth of the
phosphate headgroups. We conclude that at both neutral and acidic pH, the N-terminal of the fusion peptide is close to the
aqueous phase and is protonated. Thus neither a change in the state of ionization nor a significant increase in membrane
insertion of this group is associated with increased fusogenicity at low pH.
INTRODUCTION
Membrane fusion is involved in a wide variety of biological
processes, from sperm-oocyte fusion, to myoblast fusion
during muscle development, to intracellular membrane traf-
ficking events, as well as infection by enveloped viruses.
Elucidation of the mechanism of membrane fusion is very
important for understanding cellular processes. Influenza
virus enters target cells by receptor-mediated endocytosis
and is delivered to an intracellular acidic organelle, the
endosome. The low pH of this compartment triggers a
conformational change in the viral hemagglutinin protein
(HA), rendering it fusion-active and thus promoting the
merger between the viral envelope and the endosomal mem-
brane (Melikyan and Chernomordik, 1997; Gaudin et al.,
1995; White, 1995). Influenza virus HA, a homotrimeric
glycoprotein synthesized in infected cells as an inactive
precursor, designated HA0, becomes fusion-competent after
cleavage into two subunits, HA1 and HA2, which are joined
by disulfide bonds (Wiley and Skehel, 1987). At neutral pH,
HA trimers form spikes that project 130 Å from the viral
envelope (Ramalho-Santos and Lima, 1998), each monomer
containing a globular head region (HA1), responsible for
viral binding to sialic acid-containing receptors in target
membranes, and an envelope-anchored stem region (HA2).
HA-mediated membrane fusion only takes place after a
protein conformational change at low pH. This conforma-
tional change results in the exposure of a stretch of 20
amino acids that are located at the N-terminus of HA2. This
is a consequence of the dissociation of the globular heads of
the HA1 subunit so as to allow formation of an extended
coiled coil structure in the HA2 subunit (White and Wilson,
1987; Carr and Kim, 1993). In addition, acidification results
in the protonation of specific amino acid residues, including
several in a newly formed kinked loop (Epand et al., 1999).
Although much information has been obtained on the
structural properties of truncated forms of HA at neutral
(Wilson et al., 1981) and acidic (Bullough et al., 1994) pH,
the molecular mechanism of membrane fusion as mediated
by the influenza HA is still not well understood (Ramalho-
Santos and Lima, 1998). The role of the fusion peptide,
located at the N-terminal of HA2, in HA-mediated mem-
brane fusion has long been thought to be required for the
destabilization of the target membrane bilayer (Epand and
Epand, 1994). Indeed, several studies have shown that it is
the segment of the HA protein corresponding to the fusion
peptide that can penetrate target membranes before fusion,
suggesting that this might be the first step leading to lipid
mixing (Tsurudome et al., 1992; Harter et al., 1989; Steg-
mann et al., 1991; Durrer et al., 1996).
Further evidence for the importance of the terminal
amino group in viral fusion is that many viral fusion pep-
tides occur at the amino terminus of a viral fusion protein.
In addition, peptides blocked at the amino terminus are
often found to inhibit viral fusion, while freeing the amino
group can convert the peptide into one that promotes neg-
ative curvature strain (Epand et al., 1993), a property often
associated with more rapid rates of membrane fusion. In
addition, mutation of position 1 of HA produces a virus that
is not infectious (Gething et al., 1986) and whose fusion
peptide produces less negative curvature strain (Epand and
Epand, 1994).
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Two previous electron paramagnetic resonance (EPR)
studies, one using a labeled N-terminal 20-amino acid fu-
sion peptide and another using labeled cysteine mutants of
a longer 127-amino acid trimeric HA2 construct (FHA2),
left some uncertainty regarding the location of the amino
terminus of the fusion peptide when inserted into mem-
branes. Using the FHA2 construct, it was suggested that the
amino terminus was close to the membrane interface (Ma-
cosko et al., 1997). However, the conclusion was based on
a series of eight spin-labeled cysteine mutants at positions
5–14 in the sequence, and no data were obtained from
residues 1–4, which were assumed to be part of a continu-
ous -helix. Interestingly, this conclusion was in conflict
with the other EPR study using a 20-amino acid peptide that
was spin-labeled at the amino terminus (Lu¨neberg et al.,
1995). That work suggested that the amino terminus might
be inserted into the hydrophobic regions of the membrane.
However, the chemical modification of the amino terminus
caused by introduction of the spin label results in a loss of
the positive charge at the amino terminus. One might there-
fore anticipate that this uncharged amino terminus would
insert more deeply into the membrane. The present study
directly monitors the pKa and solvent accessibility of the
amino terminus of the fusion peptide, using 15N NMR.
EXPERIMENTAL PROCEDURES
Materials
The phospholipid used in this study, 1,2-dioleoyl-sn-glycero-3-phospho-
choline (DOPC), was purchased from Avanti Polar Lipids (Alabaster, AL).
Deuterium oxide (99.9%), 15N-labeled glycine (99%), and 15NH4NO3
(98%) were purchased from Isotec (Miamisburg, OH). Praseodymium (III)
chloride (99.99%) was obtained from Aldrich (Milwaukee, WI). Gadolin-
ium chloride (99.9%) was bought from ICN Pharmaceuticals (Plainview,
NY). The 15N-labeled peptide was made by standard solid-phase synthetic
methods, using fluoren-9-ylmethoxy carbonyl chemistry. The final purifi-
cation of the peptide was on a Hamilton PRP-1 high-performance liquid
chromatography column. The peptide was applied to the column in a
solution of dimethyl sulfoxide, trifluoroethanol, and 0.1 M ammonium
acetate (1:2:2, v:v:v), and the eluent was a gradient containing water,
ammonium acetate, and acetonitrile, with increasing acetonitrile concen-
trations. The fractions containing the purified peptide were then lyophilized
to dryness. The identity of the peptide was verified by fast-bombardment
mass spectrometry and by amino acid analysis. The peptide synthesized is
the fusion peptide of the X31 strain of influenza virus. The sequence is
GLFGAIAGFIENGWEGMIDG-amide, with G1 labeled with 15N.
The three FHA2 cysteine mutants, corresponding to the ectodomain of
the HA2 subunit of HA, were all expressed, purified, and spin labeled
following the procedure described previously (Macosko et al., 1997). Spin
label concentrations were determined by comparing double integrals of the
first derivative EPR spectra with that of a standard sample made of 100 M
4-hydroxy Tempo. For all mutants the spin labeling ratios were nearly
quantitative. Triton X-100 was purchased from Fischer Scientific (Fair
Lawn, NJ). Nickel ethylenediaminediacetic acid (NiEDDA) was gener-
ously provided by Dr. Charles Russell. Spin-labeled phospholipids were
purchased from Avanti Polar Lipids.
Sample preparation for NMR studies
CHCl3/MeOH (2:1 v/v) was added to 10 mg
15N-labeled
peptide and 151.5 mg DOPC (peptide:lipid  1:40 mol/
mol), and the mixture was sonicated for 5 min in a bath-type
sonicator. A homogeneous solution was achieved. The or-
ganic solvents were first removed with N2 and then placed
under vacuum overnight. To measure the pKa of the peptide
in DOPC vesicles, 2 ml of 50 mM sodium phosphate buffer
containing 100 mM NaCl in H2O (pH 4.0) was used to
hydrate the sample. The pH values were adjusted by titra-
tion with HCl and NaOH solutions. To use lanthanum ions,
2 ml of 10 mM sodium formate buffer was used to hydrate
the sample, then the pH was adjusted to 5.00. The 15N-
labeled peptide concentration was 2.4 mM. The sample was
sonicated with a bath-type sonicator for 60 min at 30°C.
Because the peptide may exist both within as well as outside
the small unilamellar vesicles (SUVs), the sample was son-
icated for another 40 min after the pH was changed or
lanthanum ions were added, before the NMR experiments.
Sample preparation for EPR studies
Lipid vesicles of uniform size (100 nm in diameter) con-
taining DOPC, were made as previously described (Raben-
stein and Shin, 1995). For the reconstitution, the vesicle
solution was perturbed with 0.5% octyl glucoside (final
concentration) and mixed with Triton X-100-solubilized
spin-labeled FHA2 mutant protein. The final concentration
of lipid in the mixture was 10 mM, and the protein concen-
tration was 20 M. The detergent was removed with Bio-
Bead SM2 resin (BioRad, Hercules, CA), following a col-
umn protocol (Holloway, 1973). The reconstituted vesicles
were obtained as a pellet by ultracentrifugation (100,000 
g for 1 h). The pellet was resuspended in buffer containing
100 mM NaCl and 50 mM sodium phosphate at pH 7.0.
NMR
15N and 1H NMR spectra were collected with coaxial NMR
tubes on a Bruker DRX-500 at 30°C with a 10-mm liquid-
state probe. 15N-labeled ammonium nitrate dissolved in
D2O in the inner NMR tube of the coaxial NMR tubes was
used as an external 15N chemical shift reference at 0.0 ppm,
with the D2O serving as the lock signal.
EPR experiments
All EPR spectra were taken with the spin-labeled mutants
reconstituted into large unilamellar phospholipid vesicles
(1000 Å in diameter). EPR power saturation curves were
generated as previously described (Macosko et al., 1997).
The power saturation approach has been very useful for
determining the topology and the secondary structure of
membrane-binding peptides and proteins (Macosko et al.,
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1997; Yu et al., 1994; Hubbell and Altenbach, 1994). For
example, in a membrane/water system, the nonpolar region
of a protein or peptide preferentially partitions into the
membrane phase, while the polar region prefers the aqueous
phase. Thus, depending on the location of the nitroxide spin
label, its collision rate with a polar versus a nonpolar
relaxing reagent will be different, which will give different
power saturation curves.
Using spin-labeled mutants of bacteriorhodopsin, Hub-
bell and co-workers have recently developed a method to
determine the immersion depth of the nitroxide from the
membrane surface. The method is based on determining the
ratio of the interaction of membrane-soluble (O2) and of
aqueous (M) relaxing reagents with the spin label, as deter-
mined by the power saturation curves in the presence of
each reagent (Altenbach et al., 1994). It has been found that
the natural log of this ratio is linearly proportional to the
immersion depth.
In the present work, NiEDDA complex (final concentra-
tion 200 mM) was used as M, because it is a neutral, small
(Mr  232), water-soluble complex that is stable at low pH
(only 1% free Ni2 at pH 4). To remove all of the other
nonspecific effects, we measure power saturation curves
under N2 flow conditions to obtain the interaction of nitrox-
ides in the absence of any relaxing reagents.
RESULTS
Measurements of pKa values of specific charge groups in
peptides or proteins can be made directly with NMR by
monitoring the chemical shift of a pertinent nucleus as a
function of pH (Zhu et al., 1995). In particular, in the case
of the influenza virus fusion peptide, the pKa value of the
Gly1 residue can be obtained from such measurements by
using a peptide isotopically enriched with 15N on the -NH2
group. Because the number of hydrogen atoms bonded to
the nitrogen nucleus of this residue changes with pH, its
chemical shift is highly sensitive to the state of ionization of
the residue.
We confirmed that we could accurately determine the
pKa of Gly, using
15N NMR with coaxial NMR tubes. The
15N NMR of a model sample of 48 mM 15N-labeled glycine
in buffer in the outer NMR tube (50 mM sodium phosphate
and 100 mM NaCl) was measured as a function of pH (Fig.
1). To improve the signal-to-noise ratio, proton decoupling
was used from pH 4.45 to pH 7.35. In this pH range, the
labile proton exchange should not be very fast, and an NOE
(nuclear Overhauser effect) was expected. It is obvious that
the signal of the 15N-labeled glycine in buffer has a phase
different from that of the signal of 15NH4NO3 in D2O. This
phenomenon is uncommon, but it is not difficult to under-
stand because 15N has a negative gyromagnetic ratio. Most
protons of 15NH4NO3 in D2O were replaced by deuterium,
and there is little NOE when proton decoupling is used. The
NOE for the 15NH4NO3 in D2O in the inner NMR tube must
be between 1 and 0 because a positive peak is observed
for this resonance. But the situation is different for 15N-
labeled glycine in buffer in ordinary H2O (in outer NMR
tube), where there is a strong negative NOE effect. The
NOE should be 4.93  NOE  1 because a negative
peak is observed.
To confirm the above explanations, further experiments
were conducted. 15N NMR of 48 mM 15N-labeled glycine in
buffer in the outer NMR tube (50 mM sodium phosphate
and 100 mM NaCl, pH 4.0) and 15NH4NO3 in D2O in the
inner NMR tube were measured without (Fig. 2 a) and with
(Fig. 2 b) proton decoupling. It is obvious that the two peaks
have the same phase in Fig. 2 a but have different phases in
Fig. 2 b. 15N NMR of 48 mM 15N-labeled glycine in 48 mM
citrate buffer in the outer NMR tube (pH 4.0) and
15NH4NO3 in D2O in the inner NMR tube were also mea-
sured in the presence of proton decoupling, both without
(Fig. 2 c) and with (Fig. 2 d) 5.3 mM Gd3. The two peaks
in Fig. 2 c have different phases but have the same phase in
Fig. 2 d. It is known that in the presence of the relaxation
reagent Gd3, proton-induced relaxation becomes relatively
FIGURE 1 15N NMR spectra of 48 mM [15N]Gly in 50 mM sodium
phosphate and 100 mM NaCl as a function of pH. 15NH4NO3 in D2O in the
inner NMR tube of coaxial NMR tubes was used as a reference.
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insignificant compared with electron-induced relaxation. As
a consequence, the associated NOE is quenched (Sanders
and Hunter, 1993). At higher pH, the NOE decreases be-
cause of the deprotonation (Fig. 1). The NOE is almost
equal to 1 at pH 7.35. So the 15N NMR spectra were
measured without proton decoupling from pH 8.58 to pH
11.88.
The decrease of the chemical shift of 15N-labeled glycine
with increasing pH (Fig. 1) was fitted to the Henderson-
Hasselbalch equation,
  acid base 10pH-pKa	/1 10pH-pKa	
where  is the observed 15N chemical shift at a specific pH
and acid and base represent the chemical shift values at the
low and high extremes of pH. A pKa of 9.81 was obtained
by a nonlinear least-squares fit of the data (Fig. 3). The pKa
value corresponds to the midpoint of the curve in Fig. 3. The
pKa value obtained here with
15N NMR is in excellent
agreement with the published value of 9.78 (Weast, 1986).
Measurement of the 15N NMR spectra of [15N-1Gly]-
influenza virus fusion peptide in the presence of phospho-
lipid is much more difficult than for the case of [15N]gly-
cine. Six to forthy-two hours was required to obtain one
spectrum at a reasonable signal-to-noise ratio. The reasons
for this are as follows: 1) The concentration of the peptide
is 20-fold lower than that of [15N]glycine. 2) The size of the
peptide is large compared with [15N]glycine. 3) The peptide
binds to high-molecular-weight lipid vesicles. Fig. 4 a
shows the 15N NMR spectrum of the peptide/DOPC at pH
4.18. The 15N signal of the peptide (in outer NMR tube) has
a different phase compared with the signal of the reference,
15NH4NO3 in D2O in the inner NMR tube, because proton
decoupling was used, as discussed above. It can be seen that
the chemical shift is 7.5 ppm. Fig. 4 b is the 15N NMR
spectrum of the peptide/DOPC at pH 10.30. The 15N signal
of the peptide has the same phase compared with the signal
of the reference because proton decoupling was not used
(see above). The chemical shift at this pH is4.8 ppm. Fig.
5 shows the dependence of the 15N chemical shift of the
peptide in the presence of DOPC on the pH. From a least-
squares fit to this titration curve (Fig. 5), a pKa of 8.69 was
obtained. The fit of the data to a theoretical titration curve
was excellent and indicated that the error in the measured
pKa was no greater than 
0.03. The pKa of [
15N]Gly-
peptide in the presence of DOPC is significantly higher than
that reported for other amino-terminal groups in peptides.
For example, the pKa of the -NH2 group of penta-Gly is
8.02 (Weast, 1986), 0.67 pH units lower than that found for
the fusion peptide. This shift is opposite the direction ex-
pected for insertion of the amino group of the fusion peptide
into a more hydrophobic environment of the membrane.
There are two factors that can explain the observed shift of
pH value. One is the role of membrane surface charge in
altering the interfacial pH, according to electrical double-
FIGURE 2 15N NMR of 48 mM [15N]Gly in phosphate buffer (pH 4.0)
without (a) and with (b) proton decoupling. (c and d) 15N NMR of 48 mM
[15N]Gly in 48 mM citrate buffer (pH  4.0) without (c) and with (d) 5.3
mM Gd3. 15NH4NO3 in D2O in the inner NMR tube of coaxial NMR
tubes was used as a reference.
FIGURE 3 Nonlinear least-squares fit of the 15N NMR chemical shifts
(48 mM [15N]Gly in 50 mM sodium phosphate and 100 mM NaCl) as a
function of pH.
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layer effects described by the Gouy-Chapman theory
(McLaughlin, 1989). The lipid is zwitterionic. However, the
peptide has three negatively charged carboxyl groups in the
pH range at which the amino group titrates. Because the
binding of the peptide is relatively independent of pH
(Rafalski et al., 1991), the membrane surface charge would
be negative, at least above pH 7, making the surface pH
lower than the bulk pH. However, with only 2.4 mM peptide
(2 mol%) and a maximum of three negative charges per
peptide, this effect will be small. For example, the pKa of
the N-terminal Gly of melittin in micelles is 7.90 (Zhu et al.,
1995), close to the value of 8.02 for penta-Gly, even though
melittin is a peptide with six cationic groups. Changes in the
interfacial pH may contribute to the observed shift in the
pKa of the terminal amino group of the fusion peptide to
higher values, but this is not the entire explanation. We
therefore suggest that another factor contributing to the shift
of pKa to higher values is the interaction of the -NH3

group with a negative charge, i.e., an electrostatic interac-
tion stabilizing the protonated form. Thus, the -NH3

group of the peptide may bond with one of the carboxyl
groups of the peptide or with the phosphate group of the
DOPC.
We further tested the degree of exposure of the terminal
amino group of the membrane-inserted peptide to water-
soluble cations. 1H and 15N NMR of [15N]Gly-peptide/
DOPC vesicles was measured in the presence of the shift
reagent, Pr3, placed in the outer section of a coaxial NMR
tube, and the pH was adjusted to 5.00. Fig. 6 A shows the 1H
NMR of the [15N]Gly-peptide/DOPC (1:40 mol/mol) at pH
5.0 at different Pr3 concentrations. Choline methyl and
choline methylene signals were shifted as expected, because
they are at the membrane surface. Signals from protons in
the middle of the bilayer were not affected. Although the
samples were sonicated for 40 min after additions of Pr3,
at 5.0 and 10.0 mM Pr3, some of the SUVs appear to still
only have very low concentrations of Pr3 inside the vesicle
(Fig. 6 A; the chemical shift of a fraction of the choline
methyl groups was not affected).
Changes in the chemical shift in the presence of Pr3
could be a consequence of a change in the bulk magnetic
susceptibility (BMS). Because the CH3 group of the acyl
chain should be affected only by BMS when Pr3 was
added to the sample, the absolute chemical shift change of
the CH3 group of the acyl chain was used to calculate the
BMS. The BMS is 0.08, 0.18, and 0.38 ppm when the Pr3
concentration is 5, 10, and 20 mM, respectively. Fig. 6 B
shows the 15N NMR of [15N]Gly-peptide/DOPC in the outer
NMR tube (1:40 mol/mol) at pH 5.0 at different Pr3
concentrations. The peak at 0.00 ppm is from 15NH4NO3 in
D2O in the inner NMR tube. It is obvious that the
15N signal
of [15N]Gly-peptide/DOPC was shifted to higher frequency.
The chemical shift change is 0.27, 0.51, and 0.83 ppm at 5,
10, and 20 mM Pr3, respectively. The shift is much bigger
than the BMS at corresponding Pr3 concentrations.
FIGURE 4 15N NMR spectra of [15N]1Gly influenza virus fusion pep-
tide/DOPC (1:40, mol/mol) in 50 mM sodium phosphate and 100 mM
NaCl. (a) pH 4.18; (b) pH 10.30. 15NH4NO3 in D2O in the inner NMR tube
of coaxial NMR tubes was used as a reference.
FIGURE 5 Nonlinear least-squares fits of the 15N NMR chemical shifts
([15N]1Gly influenza virus fusion peptide/DOPC in 50 mM sodium phos-
phate and 100 mM NaCl) as a function of pH.
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The membrane immersion depths based on EPR power
saturation are described in the Experimental Procedures
section. The resulting depths at pH 7.0 and 5.0 of the
nitroxide spin labels attached to each mutant are plotted in
Fig. 7. These depth measurements are consistent with pre-
vious measurements of the same mutants in SUVs (100 nm
in diameter) containing 80 mol% palmitoyloleoylphosphati-
dylcholine (POPC) and 20 mol% palmitoyloleoylphosphati-
dylglycerol (POPG) (Macosko et al., 1997). Together, these
depth measurements reflect what would be expected from
an -helix buried in the membrane at an oblique angle.
Therefore, it was possible to fit these depth data into a
standard -helix model of a 5.41-Å pitch and 1.50-Å trans-
lation per residue (Fig. 7). We found that the best fitting tilt
angles from the horizontal plane of the membrane are 25°
for pH 7.0 and 28° for pH 5.0, respectively. The best fit for
the helix rotation was consistent with its hydrophobic mo-
ment calculated based on recently determined hydrophobic-
ities of amino acid residues (Thorgeirsson et al., 1996). In
the model -helix, the paramagnetic center in the nitroxide
moiety is located 7 Å from the center axis of the helix
backbone, and the nitroxide side chain is assumed to be
extended along the line connecting the central helical axis
and the -carbon in cysteine.
We are interested in characterizing any topological
change that may take place in the fusion peptide at low pH.
In Fig. 7, the depth profiles of the fusion peptide region at
pH 7 and pH 5 are quite similar. In fact the calculated angles
differ by only 3°. This similarity is evidence that the fusion
peptide region of the HA2 domain does not undergo any
conformational change or change in angle of insertion in the
membrane as a function of pH.
DISCUSSION
There has been limited application of 15N NMR methods to
obtain the dissociation constant of N-H protons. The pKa
values of these groups are perturbed by electrostatic inter-
actions with other charged groups as well as by the polarity
of the environment of these groups. In the case of the
FIGURE 6 1H (A) and 15N (B) NMR
of [15N]Gly-peptide/DOPC (1:40 mol/
mol) at pH 5.0 at different Pr3 concen-
trations.
FIGURE 7 A plot of the measured depths at three residues of the
DOPC-bound FHA2 fusion peptide region (E,) and eight residues of the
POPC/POPG (4:1)-bound FHA2 (F, f). The fitted curves are based on a
rigid -helix (5.41-Å pitch and 1.50-Å translation per residue). The para-
magnetic center is assumed to be extended 7 Å along a line connecting the
central helical axis and the -carbon of the cysteine. The calculated tilt
angles based on all of the data are 25° and 28° from the plane of the
membrane for pH 7 and pH 5, respectively. This orientation of the helix
would position the N-terminal glycine at the phosphate headgroup region,
consistent with the NMR data presented in this study.
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influenza fusion peptide, the terminal amino group has a
pKa of 8.69 in the presence of liposomes. This value is high
for a terminal amino group and suggests that the charged
terminus of the peptide interacts with an anionic moiety.
However, the protonation of this group plays no role in
membrane fusion because its state of ionization does not
change between the fusion-inactive pH of 7.4 and pH 5,
where the rate of fusion is enhanced. It has been reported
that the influenza HA protein can induce fusion even at
neutral pH under denaturing conditions of high temperature
or the presence of urea (Carr et al., 1997). The difference in
the rate of fusion at neutral and acid pH is not affected by
the state of ionization of the terminal amino group that
remains the same.
We can also estimate whether the terminal amino group
of the peptide remains accessible to the aqueous phase when
it interacts with a membrane bilayer. The effect of lan-
thanide ions on the 15N NMR spectra suggests that the
terminal amino group remains close to the membrane sur-
face, even at acidic pH. There is evidence, however, from
the shift in the emission maximum of the Trp residue of this
peptide, from 347 nm at pH 7.4 to 330 nm at pH 5.0, in the
presence, but not in the absence, of liposomes of phosphati-
dylcholine (Rafalski et al., 1991; Lear and DeGrado, 1987)
that there is a deeper insertion of the peptide at low pH.
However, fluorescence quenching experiments of Trp argue
against this conclusion and are in accord with the suggestion
that there is no change in the depth of insertion of the
peptide with pH (Clague et al., 1991). An alternative role of
acidification is that the protonation of the acidic amino acid
residues in the fusion peptide region allows for closer prox-
imity in the membrane by lowering the electrostatic repul-
sion. A somewhat analogous situation occurs with succiny-
lated melittin. This peptide cannot induce fusion at neutral
pH but causes a rapid and efficient fusion at acidic pH
concomitant with protonation of the carboxyl groups (Mu-
rata et al., 1987). The unmodified melittin, which does not
contain the carboxyl groups of succinate, induces fusion in
a pH-independent manner (Morgan et al., 1983; Eytan and
Almary, 1983).
Using synthetic peptides corresponding to the N-terminus
of several HAs, both -helical and -strands were detected,
with a slight predominance of the former structure (Gray et
al., 1996). It has been reported that these small, synthetic
fusion peptides insert into target membranes at an oblique
angle as an -helix (Gray et al., 1996; Lu¨neberg et al.,
1995). Moreover, the membrane topology of a homotrim-
eric, 14-kDa HA2 construct, FHA2, was determined by EPR
techniques (Macosko et al., 1997). The fusion peptide re-
gion of this construct, which promotes lipid mixing in
conditions and at rates identical to those of native HA
(Epand et al., 1999), was found to be locally monomeric and
tilted 30° with respect to the plane of an anionic membrane.
Because the influenza fusion peptide has charged groups
that may interact with charges in the lipid headgroup, it was
important to test whether the conformation and the extent
and angle of membrane insertion of the peptide were the
same in zwitterionic as in anionic lipids. In the present study
it is shown that the mode of insertion of the fusion peptide
is not sensitive to the presence of anionic lipids. This mode
of insertion also explains how the terminal amino group can
be close to the membrane interface, even though the peptide
is inserted into the membrane with the amino group entering
first. It is a consequence of one face of the -helix, which
includes the N-terminal Gly residue, being oriented toward
the aqueous phase (Fig. 7).
The results show that the -NH2 group remains proton-
ated between a pH of 5 and 7.4. However, at pH 5 but not
at pH 7, this peptide is active in promoting formation of a
cubic phase in certain lipids (Colotto and Epand, 1997) and
in promoting lipid mixing at very high peptide concentra-
tions (Lear and DeGrado, 1987). The only groups on the
peptide that are likely to change their state of ionization
between neutral and acid pH are the three side-chain car-
boxyl groups. The protonation of these groups is suggested
not to change the angle of insertion of the peptide into
bilayers (Lu¨neberg et al., 1995), and it does not significantly
affect the depth of burial of the fusion peptide in the
membrane (Macosko et al., 1997, and the present work). It
should be pointed out, however, that these acidic amino
acids are not required for fusion and they can be replaced by
mutagenesis (Steinhauer et al., 1995). The fact remains that
under physiological conditions the rate of fusion promoted
by the native HA molecule is greatly increased by acidifi-
cation. From this paper and our earlier work (Macosko et
al., 1997) it appears that the nature of the insertion of the
fusion peptide into a membrane is not significantly affected
by pH, and the terminal amino group remains protonated
and exposed to the aqueous environment, even at acidic pH.
Because much of the fusion peptide is positioned in the
most rigid and tightly packed region of the bilayer, it is
possible that small changes in the depth or angle of insertion
of the peptide can have marked effects on the properties of
the membrane. Alternatively, at neutral pH, the three ion-
ized carboxyl groups on the exposed face of the fusion
peptide region could prevent the fusion peptide-bound
membrane from coming in close proximity to the target
membrane because of electrostatic repulsion and/or an in-
creased hydration barrier. 1H NMR shows that vesicles do
not aggregate at neutral or basic pH (data not shown). At
acidic pH, membranes are aggregated by the peptide, aided
by the loss of electrostatic repulsion. Furthermore, the
change in peptide charge would favor more negative intrin-
sic curvature, thereby destabilizing the membrane and fa-
cilitating the formation of the initial fusion intermediate.
In summary, despite the importance of the amino termi-
nus of HA2 to membrane fusion, its state of ionization and
position in the membrane are not significantly altered by a
decrease in pH from 7 to 5.
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